Palladio Biosciences
0 followers
Palladio Biosciences, Inc., is a Centessa company. Their first product, lixivaptan, is in Phase 3 clinical development for the treatment of autosomal polycystic kidney disease (ADPKD). ADPKD causes numerous fluid-filled cysts to grow in both kidneys. It is a life-limiting, chronic and progressive d... Read more
Org chart
Alex Martin
CEO
Alex Martin
Collapse
Lorenzo Pellegrini
Founder & COO
Ron Dadino
VP of CMC & Manufacturing Head of Quality
Amy Murnane
VP of Project Management
Marcus Abraitis
VP of Finance
Milena Kanova
VP of Clinical Operations
